Hui‐Ping Hsu

1.9k citations
67 papers · 1.5k indexed · h-index 24
Topics
Cancer Cells and Metastasis (9 papers)Pancreatic and Hepatic Oncology Research (9 papers)Cancer, Hypoxia, and Metabolism (9 papers)

In The Last Decade

Hui‐Ping Hsu

66 papers receiving 1.5k citations

Peers

Hui‐Ping Hsu
Comparison fields: 5 of 111
  • Molecular Biology 695
  • Oncology 489
  • Cancer Research 384
  • Pulmonary and Respiratory Medicine 293
  • Surgery 253
Replace Toshio Seyama with:
Toshio Seyama Japan
Chang-Fang Chiu Taiwan
Padma Kumar Narayanan United States
C. Luccioni France
Hiroshi Eto Japan
Hongning Zhou United States
Rosana Eisenberg United States
H. Rabes Germany
L. M. van Putten Netherlands
Archana M. Agarwal United States
Hui‐Ping Hsu relative to Toshio Seyama Japan Toshio Seyama's profile →
Citations per field
00.5×6.8×
Toshio Seyama · 1×
Citations per year

Countries citing papers authored by Hui‐Ping Hsu

Since Specialization
Citations

This map shows the geographic impact of Hui‐Ping Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ping Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ping Hsu more than expected).

Fields of papers citing papers by Hui‐Ping Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Ping Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ping Hsu. The network helps show where Hui‐Ping Hsu may publish in the future.

Co-authorship network of co-authors of Hui‐Ping Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Ping Hsu. A scholar is included among the top collaborators of Hui‐Ping Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Ping Hsu. Hui‐Ping Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 36
4 5
5 3
6 30
7 23
8 22
9 7
10 35
11 1
12 46
13 28
14 18
15 15
16 23
17 61
18 79
19 7
20 106

About Hui‐Ping Hsu

Hui‐Ping Hsu is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 67 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). The work is most often cited by research in Cancer Research (384 citations), Oncology (489 citations) and Radiological and Ultrasound Technology (73 citations). Hui‐Ping Hsu has collaborated with scholars based in Taiwan, United States and Vietnam. Frequent co-authors include Chih‐Yang Wang, Yan‐Shen Shan, Ming-Derg Lai, Meng‐Chi Yen, Yi‐Ling Chen, Ming‐Derg Lai, Nam Nhut Phan, Pin-Wen Lin, Wei-Ching Chen and Tzu‐Yang Weng. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026